Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 44%
Hold 44%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is well positioned to benefit from the continued trend of providing safe, high-quality care in the home due to its diversified home care platform that specifically targets medically complex, high-cost patient populations. The company's success in securing preferred payor agreements and its expertise in providing specialized care for children with medical complexities allows for strong top-line growth and margin expansion, aided by cost-saving initiatives. As a consolidator in the fragmented home health sub-sector, Aveanna is also poised for further growth through M&A opportunities. Additionally, the company's strong cash flow generation and commitment to ongoing deleveraging make it a sound investment choice for future growth.

Bears say

Aveanna Healthcare Hldgs is currently facing numerous challenges that put the company at risk for underperformance, including potential reimbursement pressures, high leverage, and competition. While the company has shown strong progress in implementing its preferred payor strategy and generating good free cash flow, it is also facing potential contraction in industry multiples and slowdown in organic growth. As such, a negative outlook is justified due to the company's current risks and uncertain outlook.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 44% recommend Buy, 44% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.